- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03148496
Tissue Reinforcement of Incisional Closure Among High Risk Patients
Half of all individuals will undergo abdominal surgery in their lifetime. Following abdominal surgery, 30% of patients will suffer a major chronic complication with their wound closure in the first post-operative year. This may include significant wound infections, open wounds, fluid collections, fascial dehiscence, or incisional hernia. These complications not only have a substantial impact on the health care system (cost and chronic disease) and the hospital (cost and space), but most importantly have a substantial impact on the patient. Major chronic wound complications adversely impact patient quality of life and function. Potential methods to reduce major wound complications include utilizing specific suturing techniques or reinforcing the incision line. Suturing technique of small-bites (0.5x0.5 cm bites) as opposed to large bites (1.0x1.0 cm bites) has been shown to be efficacious in European populations with a typical body mass index of 20-25 kg/m2. Tissue reinforcement has been shown to decrease rates of major wound complications in small randomized controlled trials.
However, the lack of widespread adoption of these practices may be due to issues of generalizability including strict inclusion criteria, careful patient selection, and small study size. For example, the generalizability of small bites to an overweight population (mean BMI in the United States is 28 kg/m2) as opposed to a normal-weight population are unclear. The use of synthetic materials in comorbid patients or complex settings may risk major wound complications such as prosthetic infection. Biologic materials have been shown to be effective in decreasing major wound complications but in different settings. This study is being done to assess the effectiveness of different efficacious strategies to decrease the rate of major wound complications following abdominal surgery among high-risk individuals The researchers hypothesize:
- Among high-risk patients undergoing abdominal surgery, the use of "small-bites" closure as opposed to "large-bites" closure will increase the proportion of patients who are free of major, chronic wound complications at 1-year post-operative.
- Among high-risk patients undergoing abdominal surgery, the biologic tissue reinforcement of the suture line as opposed to no reinforcement will increase the proportion of patients who are free of major, chronic wound complications at 1-year post-operative.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
Houston, Texas, United States, 77026
- Lyndon B. Johnson (LBJ) Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
All high-risk patients undergoing laparotomy or laparoscopic-assisted abdominal surgery. This includes:
- all overweight patients (BMI>=25 kg/m2),
- current smokers,
- those who are immunosuppressed,
- those who are malnourished, or
- those who are undergoing a contaminated case (CDC wound classification of 2 or 3).
Exclusion Criteria:
- patients unlikely to follow-up in a year (e.g. no phone or lives out of state),
- patients unlikely to survive more than 2 years based upon surgeon judgment (e.g. metastatic cancer, end-stage cirrhosis),
- patients where the clinician would not place prosthetic (e.g. pregnant patient, pediatric patient during growth stage),
- patient has a planned second surgery within the next year (e.g. ostomy reversal).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Biologic Mesh and Small Bites
Biologic mesh placement and small bites used for suturing.
|
Biologic mesh placed during surgery
0.5 cm x 0.5 cm sutures used
|
Experimental: Small Bites and No Biologic Mesh
Small bites used for suturing with no placement of biologic mesh
|
0.5 cm x 0.5 cm sutures used
|
Experimental: Biologic mesh and Large Bites
Biologic mesh placement and large bites used for suturing
|
Biologic mesh placed during surgery
1.0 x 1.0 sutures used
|
Active Comparator: Large Bites and no biologic mesh
Large bites used for suturing and no placement of biologic mesh.
|
1.0 x 1.0 sutures used
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of Participants Major Chronic Wound Infection
Time Frame: 1 year after surgery
|
Proportion of participants with major chronic wound infection
|
1 year after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Major Complications
Time Frame: 1 year after surgery
|
Major complications include surgical site infection, ventral incisional hernia, and/or reoperation
|
1 year after surgery
|
Number of Participants With Surgical Site Infections
Time Frame: 1 year after surgery
|
1 year after surgery
|
|
Number of Participants With Reoperations
Time Frame: 1 year after surgery
|
any unplanned invasive procedure involving the fascia, mesh, or peritoneal cavity
|
1 year after surgery
|
Operative Duration
Time Frame: about 119 minutes to 337 minutes
|
length of the entire procedure
|
about 119 minutes to 337 minutes
|
Participants Quality of Life as Assessed by Activities Assessment Scale
Time Frame: 1 year after surgery
|
Quality of life is scored from 1 to 100, where the higher the score the higher quality of life
|
1 year after surgery
|
Participants Health Status as Assessed by the Euroqol-5D Questionnaire
Time Frame: 1 year after surgery
|
Health Status is scored from 0 to 100, where the higher the score the better the health
|
1 year after surgery
|
Cost Analyses
Time Frame: 1 year after surgery
|
calculated from the hospital's perspective by assessing charges for all patient visits, admissions, and procedures
|
1 year after surgery
|
Surgeon Perception
Time Frame: 1 year after surgery
|
likert type and open ended questions assessing perception, barriers and likelihood of utilizing interventions outside of the trial
|
1 year after surgery
|
Number of Participants With Major Complications
Time Frame: 3 years after surgery
|
Major complications include surgical site infection, ventral incisional hernia, and/or reoperation
|
3 years after surgery
|
Number of Participants With Surgical Site Infections
Time Frame: 3 years after surgery
|
3 years after surgery
|
|
Number of Participants With Reoperations
Time Frame: 3 years after surgery
|
any unplanned invasive procedure involving the fascia, mesh, or peritoneal cavity
|
3 years after surgery
|
Participants Quality of Life as Assessed by Activities Assessment Scale
Time Frame: 3 years after surgery
|
Quality of life is scored from 1 to 100, where the higher the score the higher quality of life
|
3 years after surgery
|
Participants Health Status as Assessed by the Euroqol-5D Questionnaire
Time Frame: 3 years after surgery
|
Health Status is scored from 0 to 100, where the higher the score the better the health
|
3 years after surgery
|
Cost Analyses
Time Frame: 3 years after surgery
|
calculated from the hospital's perspective by assessing charges for all patient visits, admissions, and procedures
|
3 years after surgery
|
Surgeon Perception
Time Frame: 3 years after surgery
|
likert type and open ended questions assessing perception, barriers and likelihood of utilizing interventions outside of the trial
|
3 years after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Julie Holihan, MD, The University of Texas Health Science Center, Houston
Publications and helpful links
General Publications
- Armananzas L, Ruiz-Tovar J, Arroyo A, Garcia-Peche P, Armananzas E, Diez M, Galindo I, Calpena R. Prophylactic mesh vs suture in the closure of the umbilical trocar site after laparoscopic cholecystectomy in high-risk patients for incisional hernia. A randomized clinical trial. J Am Coll Surg. 2014 May;218(5):960-8. doi: 10.1016/j.jamcollsurg.2014.01.049. Epub 2014 Feb 18.
- Millbourn D, Cengiz Y, Israelsson LA. Effect of stitch length on wound complications after closure of midline incisions: a randomized controlled trial. Arch Surg. 2009 Nov;144(11):1056-9. doi: 10.1001/archsurg.2009.189.
- Goodenough CJ, Ko TC, Kao LS, Nguyen MT, Holihan JL, Alawadi Z, Nguyen DH, Flores JR, Arita NT, Roth JS, Liang MK. Development and validation of a risk stratification score for ventral incisional hernia after abdominal surgery: hernia expectation rates in intra-abdominal surgery (the HERNIA Project). J Am Coll Surg. 2015 Apr;220(4):405-13. doi: 10.1016/j.jamcollsurg.2014.12.027. Epub 2015 Jan 2.
- McCarthy M Jr, Jonasson O, Chang CH, Pickard AS, Giobbie-Hurder A, Gibbs J, Edelman P, Fitzgibbons R, Neumayer L. Assessment of patient functional status after surgery. J Am Coll Surg. 2005 Aug;201(2):171-8. doi: 10.1016/j.jamcollsurg.2005.03.035. Erratum In: J Am Coll Surg. 2005 Nov;201(5):826.
- Hawn MT, Itani KM, Giobbie-Hurder A, McCarthy M Jr, Jonasson O, Neumayer LA. Patient-reported outcomes after inguinal herniorrhaphy. Surgery. 2006 Aug;140(2):198-205. doi: 10.1016/j.surg.2006.02.003.
- Blackstock R, Hernandez NC. Characterization of the macrophage subset affected and its response to a T suppressor factor (TsFmp) found in cryptococcosis. Infect Immun. 1989 Oct;57(10):2931-7. doi: 10.1128/iai.57.10.2931-2937.1989.
- Holihan JL, Henchcliffe BE, Mo J, Flores-Gonzalez JR, Ko TC, Kao LS, Liang MK. Is Nonoperative Management Warranted in Ventral Hernia Patients With Comorbidities?: A Case-matched, Prospective, Patient-centered Study. Ann Surg. 2016 Oct;264(4):585-90. doi: 10.1097/SLA.0000000000001865.
- Deerenberg EB, Harlaar JJ, Steyerberg EW, Lont HE, van Doorn HC, Heisterkamp J, Wijnhoven BP, Schouten WR, Cense HA, Stockmann HB, Berends FJ, Dijkhuizen FPH, Dwarkasing RS, Jairam AP, van Ramshorst GH, Kleinrensink GJ, Jeekel J, Lange JF. Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial. Lancet. 2015 Sep 26;386(10000):1254-1260. doi: 10.1016/S0140-6736(15)60459-7. Epub 2015 Jul 15.
- Millbourn D, Cengiz Y, Israelsson LA. Risk factors for wound complications in midline abdominal incisions related to the size of stitches. Hernia. 2011 Jun;15(3):261-6. doi: 10.1007/s10029-010-0775-8. Epub 2011 Jan 30.
- Bhangu A, Fitzgerald JE, Singh P, Battersby N, Marriott P, Pinkney T. Systematic review and meta-analysis of prophylactic mesh placement for prevention of incisional hernia following midline laparotomy. Hernia. 2013 Aug;17(4):445-55. doi: 10.1007/s10029-013-1119-2. Epub 2013 May 28.
- Fortelny RH, Hofmann A, May C, Kockerling F; BioMesh Study Group. Prevention of a Parastomal Hernia by Biological Mesh Reinforcement. Front Surg. 2015 Oct 22;2:53. doi: 10.3389/fsurg.2015.00053. eCollection 2015.
- Muysoms FE, Detry O, Vierendeels T, Huyghe M, Miserez M, Ruppert M, Tollens T, Defraigne JO, Berrevoet F. Prevention of Incisional Hernias by Prophylactic Mesh-augmented Reinforcement of Midline Laparotomies for Abdominal Aortic Aneurysm Treatment: A Randomized Controlled Trial. Ann Surg. 2016 Apr;263(4):638-45. doi: 10.1097/SLA.0000000000001369.
- Sarr MG, Hutcher NE, Snyder S, Hodde J, Carmody B. A prospective, randomized, multicenter trial of Surgisis Gold, a biologic prosthetic, as a sublay reinforcement of the fascial closure after open bariatric surgery. Surgery. 2014 Oct;156(4):902-8. doi: 10.1016/j.surg.2014.06.022.
- Bali C, Papakostas J, Georgiou G, Kouvelos G, Avgos S, Arnaoutoglou E, Papadopoulos G, Matsagkas M. A comparative study of sutured versus bovine pericardium mesh abdominal closure after open abdominal aortic aneurysm repair. Hernia. 2015 Apr;19(2):267-71. doi: 10.1007/s10029-014-1262-4. Epub 2014 May 13.
- Ferzoco SJ. A systematic review of outcomes following repair of complex ventral incisional hernias with biologic mesh. Int Surg. 2013 Oct-Dec;98(4):399-408. doi: 10.9738/INTSURG-D-12-00002.1.
- Stampfer MJ, Buring JE, Willett W, Rosner B, Eberlein K, Hennekens CH. The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians. Stat Med. 1985 Apr-Jun;4(2):111-6. doi: 10.1002/sim.4780040202.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- HSC-MS-17-0063
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Complication
-
Indus Hospital and Health NetworkCompletedWound Closure After Total Knee Arthroplasty: Comparison of Polypropylene and Polyglactin 910 Suture.Wound Heal | Wound Complication | Wound DehiscencePakistan
-
Royal North Shore HospitalUnknown
-
Chulalongkorn UniversityUnknownWound Heal | Wound Surgical | Donor Site ComplicationThailand
-
Marmara UniversityCompletedWound Healing Complication
-
Columbia UniversityKinetic Concepts, Inc.CompletedWound ComplicationUnited States, Canada
-
Silver Falls DermatologySamaritan Health ServicesUnknownSurgery | Wound | Suture, Complication | Wound Complication | Wound of Skin | Suture; Complications, Infection or Inflammation | Wound DehiscenceUnited States
-
Rothman Institute OrthopaedicsEnrolling by invitation
-
Washington University School of MedicineCompletedWound Infection | Wound ComplicationUnited States
-
St James Connolly Memorial HospitalUnknownWound Infection | Wound ComplicationIreland
-
Scripps HealthNorth Park PodiatryNot yet recruitingAmputation | Wound; Foot | Wound Complication
Clinical Trials on Biologic Mesh
-
University of CalgaryMedtronicRecruiting
-
The University of Texas Health Science Center,...Completed
-
Assistance Publique - Hôpitaux de ParisCompletedIncisional Hernia After Diverting Stoma ClosureFrance
-
Michigan Institution of Women's Health PCColoplast A/SActive, not recruitingPelvic Organ ProlapseUnited States
-
Michael RosenCompleted
-
University Hospitals Cleveland Medical CenterBard LtdTerminatedVentral HerniaUnited States
-
Erasmus Medical CenterJohann Wolfgang Goethe University Hospital; Technical University of Munich; St... and other collaboratorsUnknownHernia of Abdominal Wall | Biologic Mesh | StratticeGermany
-
The University of Texas Health Science Center,...Withdrawn
-
DermTechRecruitingAtopic DermatitisUnited States
-
University of Missouri-ColumbiaCompletedKnee Osteoarthritis | Post-traumatic OsteoarthritisUnited States